Showing results (361-370 of 781) with videos related to
Sort By:
Pageof 79
Journal of Attention Disorders|May 2, 2008
Long-term, open-label safety and efficacy of atomoxetine in adults with ADHD: final report of a 4-year studyLenard A Adler, Thomas J Spencer, David W Williams, et al.ACS Synthetic Biology|August 1, 2013
SCHEMA computational design of virus capsid chimeras: calibrating how genome packaging, protection, and transduction correlate with calculated structural disruptionMichelle L Ho, Benjamin A Adler, Michael L Torre, et al.Ultraschall in Der Medizin (Stuttgart, Germany : 1980)|August 1, 1993
[Late complication of tubal pregnancy visualized with color Doppler ultrasound. A case report]E Asseryanis, B Schurz, W Eppel, et al.Computational Psychiatry (Cambridge, Mass.)|November 2, 2018
A Low-Level Perceptual Correlate of Behavioral and Clinical Deficits in ADHDAndra Mihali, Allison G Young, Lenard A Adler, et al.Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|February 11, 1991
Lack of efficacy of d-propranolol in neuroleptic-induced akathisiaL A Adler, B Angrist, P Fritz, et al.Journal of Clinical Microbiology|November 2, 2012
Environmental contamination by carbapenem-resistant EnterobacteriaceaeA Lerner, A Adler, J Abu-Hanna, et al.Case Reports in Ophthalmology|May 14, 2015
Conjunctival Attachment of a Live Paralysis Tick, Ixodes holocyclus, in a Child: A Case ReportJoanne M Y Teong, Paul A Adler, Stephen L Doggett, et al.Spinal Cord|October 24, 2018
Serum testosterone levels may influence body composition and cardiometabolic health in men with spinal cord injurySally M Abilmona, Ryan M Sumrell, Ranjodh S Gill, et al.Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|December 9, 2004
Improving osteoporosis management in patients with fracturesS L Johnson, V I Petkov, M I Williams, et al.Biological Psychiatry|February 28, 2006
ABT-089, a neuronal nicotinic receptor partial agonist, for the treatment of attention-deficit/hyperactivity disorder in adults: results of a pilot studyTimothy E Wilens, Marleen H Verlinden, Lenard A Adler, et al.Pageof 79